Swiss Pharma Company – IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat)

TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei’s efficacy at an unprecedented level in weight loss and satiety

The French biotech TargEDys specialized in breakthrough microbiome-based solutions announces the publication of its study conducted in 230 overweight adults supplemented for 12 weeks, confirming the efficacy of the precision probiotic Hafnia alvei HA4597® to improve weight loss, hip circumference reduction and metabolic parameters thanks to the action of the probiotic and its postbiotic ClpB on feeling […]

New Scientific Support for Curcugen’s enhanced bioavailability

Landing, NJ — DolCas Biotech, LLC announces release of pharmacokinetic data in support of the 39-fold-enhanced bioavailability of free curcumin claim for its Curcugen® curcumin extract. The 17-subjectrandomized, double-blind, crossover study 1 published July 9 (volume 100) in the journal Medicine by Sanjib Panda, MPh, et alia, evaluated the dispersible, 98.5% native turmeric (50% curcuminoid […]

Anatara’s IBS-D clinical trial to leverage Microba Life Sciences’ precision microbiome analysis

Precision microbiome science company, Microba Life Sciences, will work with Anatara Life Sciences (ASX:ANR) to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D. Anatara have commenced recruitment for a phase 1/2 clinical trial of their Gastrointestinal Re-Programming complementary medicine (GaRP) to address an unmet clinical need for IBS-D.   Microba will apply […]